Health

health

FDA approves a new weight loss drug, Zepbound from Eli Lilly

The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well. While Mounjaro had already been used by some patients “off-label” for weight loss, the new …

Read More »